AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Oct 30, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 230
- +13 vs. Q2 2024
- Portfolio value
- $134.5M
- −$1.28M (−0.9%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRNAVerona Pharma plc | SPONSORED ADS | 50,000 | $1.44M | 1.1% | −6,000−10.7% | Reduced | History |
| AMPHAmphastar Pharmaceuticals, Inc. | COM | 30,000 | $1.46M | 1.1% | +5,000+20.0% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 20,000 | $1.46M | 1.1% | 00.0% | Unchanged | History |
| ELSEquity Lifestyle Properties Inc | COM | 20,611 | $1.47M | 1.1% | 00.0% | Unchanged | History |
| ACTEnact Holdings, Inc. | COM | 42,367 | $1.54M | 1.1% | 00.0% | Unchanged | History |
| MITTTPG Mortgage Investment Trust, Inc. | COM NEW | 208,879 | $1.57M | 1.2% | 00.0% | Unchanged | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 15,500 | $1.73M | 1.3% | +4,500+40.9% | Added | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 45,000 | $1.75M | 1.3% | −19,000−29.7% | Reduced | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 67,500 | $1.91M | 1.4% | +7,500+12.5% | Added | History |
| Invesco Nasdaq 100 ETF46138G649 | ETF | 10,158 | $2.04M | 1.5% | +2,259+28.6% | Added | – |
| Invesco QQQ Trust Series I46090E103 | ETF | 4,182 | $2.04M | 1.5% | +925+28.4% | Added | – |
| EXASExact Sciences Corp | COM | 30,000 | $2.04M | 1.5% | 00.0% | Unchanged | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 370,000 | $2.06M | 1.5% | +370,000 | New | History |
| MFAMfa Financial, Inc. | COM | 167,725 | $2.13M | 1.6% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 205,000 | $2.19M | 1.6% | +2,500+1.2% | Added | History |
| RWTRedwood Trust Inc | COM | 288,343 | $2.23M | 1.7% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 6,250 | $2.24M | 1.7% | −8,250−56.9% | Reduced | History |
| DVAXDynavax Technologies Corp | COM NEW | 201,500 | $2.24M | 1.7% | +71,500+55.0% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 18,000 | $2.25M | 1.7% | +10,500+140.0% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 32,500 | $2.28M | 1.7% | +16,000+97.0% | Added | History |
| DXDynex Capital Inc | COM | 181,492 | $2.32M | 1.7% | 00.0% | Unchanged | History |
| INDVIndivior Pharmaceuticals, Inc. | ORD | 242,500 | $2.36M | 1.8% | +242,500 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 4,500 | $2.44M | 1.8% | −2,750−37.9% | Reduced | History |
| MTGMgic Investment Corp | COM | 99,379 | $2.54M | 1.9% | −15,000−13.1% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 22,500 | $2.59M | 1.9% | +15,500+221.4% | Added | History |
| EFCEllington Financial Inc. | COM | 201,602 | $2.60M | 1.9% | 00.0% | Unchanged | History |
| MRKMerck & Co., Inc. | Stock | 24,000 | $2.73M | 2.0% | +24,000 | New | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 108,500 | $3.12M | 2.3% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 97,000 | $3.88M | 2.9% | −25,000−20.5% | Reduced | History |
| RITMRithm Capital Corp. | REIT | 380,966 | $4.32M | 3.2% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (15)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| BCRXBiocryst Pharmaceuticals Inc | COM | 675,000 | $4.17M | 3.1% | History |
| PCRXPacira BioSciences, Inc. | COM | 117,500 | $3.36M | 2.5% | History |
| QUREuniQure N.V. | SHS | 460,000 | $2.06M | 1.5% | History |
| DCGODocGo Inc. | COM | 650,000 | $2.01M | 1.5% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 42,500 | $1.74M | 1.3% | History |
| RWT Hldgs Inc749772AD1 | CONVERTIBLE BOND | 1,000,000 | $975.0K | 0.7% | – |
| NARIInari Medical, Inc. | Stock | 15,000 | $722.3K | 0.5% | History |
| CABACabaletta Bio, Inc. | COM | 70,000 | $523.6K | 0.4% | History |
| Redwood Trust Inc758075AF2 | NOTE 7.750% 6/1 | 500,000 | $485.9K | 0.4% | – |
| iShares Russell 1000 Value ETF464287598 | ETF | 2,762 | $481.9K | 0.4% | – |
| Invesco Exchange Traded FD T46137V258 | S&P500 PUR VAL | 5,715 | $476.7K | 0.4% | – |
| AUPHAurinia Pharmaceuticals Inc. | COM | 80,000 | $456.8K | 0.3% | History |
| iShares Inc464286715 | MSCI TURKEY ETF | 2,894 | $121.6K | 0.1% | – |
| KALVKalVista Pharmaceuticals, Inc. | COM | 2,500 | $29.4K | <0.1% | History |
| VTYXVentyx Biosciences, Inc. | COM | 10,000 | $23.1K | <0.1% | History |